Consolidated Statements of Cash Flows - USD ($) $ in Thousands		12 Months Ended
		Dec. 29, 2018	Dec. 30, 2017	Dec. 31, 2016
Cash flows from operating activities:
Net income		$ 105,944	$ 133,354	$ 107,224
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		321,192	302,100	289,908
Deferred income taxes		(16,974)	(98,805)	(11,532)
Loss/(gain) on sale of assets		709	(237)	1,744
Gain (Loss) on Disposition of Business		12,545	885	0
Asset Impairment Charges		2,907	0	0
Gain on insurance proceeds from insurance settlement		(1,253)	(1,427)	(356)
Increase/(decrease) in long-term pension liability		1,463	2,383	(430)
Stock-based compensation expense		18,779	17,598	10,330
Debt extinguishment costs		23,509	0	0
Write-off deferred loan costs		320	766	528
Deferred loan cost amortization		7,870	8,736	11,171
Equity in net income of unconsolidated subsidiaries		(159,229)	(28,504)	(70,379)
Distributions of earnings from unconsolidated subsidiaries		67,638	26,761	26,317
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable		(6,347)	3,482	(22,796)
Income taxes refundable/payable		(9,809)	9,360	2,839
Inventories and prepaid expenses		2,391	(15,022)	15,343
Accounts payable and accrued expenses		14,534	73,386	39,286
Other		12,426	(24,380)	(8,199)
Net cash provided by operating activities		398,615	410,436	390,998
Cash flows from investing activities:
Capital expenditures	[1]	(321,896)	(274,168)	(243,523)
Acquisitions, net of cash acquired		(107,727)	(12,144)	(8,511)
Investment in unconsolidated subsidiary		(12,250)	(4,750)	0
Proceeds from sale of investment in subsidiary		82,760	0	0
Gross proceeds from sale of property, plant and equipment and other assets		19,328	8,090	7,329
Proceeds from insurance settlement		1,253	6,054	1,537
Payments related to routes and other intangibles		(3,883)	(7,135)	(23)
Net cash used in investing activities		(342,415)	(284,053)	(243,191)
Cash flows from financing activities:
Proceeds from long-term debt		624,620	33,401	36,327
Payments on long-term debt		(686,628)	(149,623)	(204,428)
Borrowings from revolving credit facility		543,898	199,495	99,276
Payments on revolving credit facility		(510,974)	(204,935)	(104,028)
Net cash overdraft financing		3,460	(714)	1,071
Deferred loan costs		(9,668)	(6,717)	(3,879)
Issuance of common stock		182	22	188
Repurchase of common stock		0	0	(5,000)
Minimum withholding taxes paid on stock awards		(2,215)	(3,049)	(1,843)
Deductions of noncontrolling interest		0	(17,451)	0
Distributions to noncontrolling interests		(10,257)	(5,281)	(1,552)
Net cash used in financing activities		(47,582)	(154,852)	(183,868)
Effect of exchange rate changes on cash flows		(8,165)	20,528	(6,297)
Net increase/(decrease) in cash, cash equivalents and restricted cash		453	(7,941)	(42,358)
Cash, cash equivalents and restricted cash at beginning of year		106,916	114,857	157,215
Cash, cash equivalents and restricted cash at end of year		107,369	106,916	114,857
Supplemental disclosure of cash flow information:
Accrued Capital Expenditures		5,951	1,521	(937)
Cash paid during the year for:
Interest, net of capitalized interest		75,006	78,233	82,094
Income taxes, net of refunds		33,162	26,304	23,220
Non-cash financing activities
Debt issued for service contract assets		22	9,459	10
Contribution of Property		$ 0	$ 0	$ 2,674

[1] Excludes capital assets acquired by acquisition in fiscal 2018 of approximately $31.6 million and excludes immaterial capital assets acquired by acquisition in fiscal 2017 and fiscal 2016.